| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.474 | 29.901 | 14.414 | 2.067 | 0 | 17.944 | 33.075 | 55.795 | 50.243 | 38.072 |
| Total Income - EUR | 10.481 | 29.901 | 14.414 | 2.067 | 0 | 17.944 | 33.108 | 55.797 | 50.305 | 38.072 |
| Total Expenses - EUR | 6.142 | 20.408 | 15.032 | 2.129 | 0 | 2.869 | 3.255 | 17.137 | 21.518 | 17.808 |
| Gross Profit/Loss - EUR | 4.339 | 9.493 | -618 | -62 | 0 | 15.075 | 29.853 | 38.660 | 28.787 | 20.264 |
| Net Profit/Loss - EUR | 4.025 | 8.744 | -1.045 | -124 | 0 | 14.922 | 28.913 | 37.187 | 28.294 | 19.891 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Biotiensnat S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.050 |
| Current Assets | 3.328 | 10.989 | 10.387 | 9.954 | 9.761 | 24.683 | 29.252 | 37.994 | 29.666 | 20.773 |
| Inventories | 890 | 3.315 | 2.106 | 0 | 0 | 1.010 | 0 | 4.505 | 595 | 0 |
| Receivables | 24 | 15 | 649 | 354 | 347 | 964 | 371 | 382 | 9.992 | 10.225 |
| Cash | 2.415 | 7.659 | 7.632 | 9.600 | 9.414 | 22.709 | 28.881 | 33.107 | 19.079 | 10.548 |
| Shareholders Funds | 2.791 | 11.506 | 10.266 | 9.954 | 9.761 | 24.498 | 29.058 | 37.379 | 28.342 | 19.939 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 538 | 391 | 121 | 0 | 0 | 184 | 194 | 614 | 1.324 | 1.884 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
7410
|
|||||||||
Comments - Biotiensnat S.r.l.